Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

8.0%

4 terminated/withdrawn out of 50 trials

Success Rate

84.0%

-2.5% vs industry average

Late-Stage Pipeline

16%

8 trials in Phase 3/4

Results Transparency

0%

0 of 21 completed trials have results

Key Signals

16 recruiting

Enrollment Performance

Analytics

N/A
20(54.1%)
Phase 2
8(21.6%)
Phase 4
5(13.5%)
Phase 3
3(8.1%)
Phase 1
1(2.7%)
37Total
N/A(20)
Phase 2(8)
Phase 4(5)
Phase 3(3)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (50)

Showing 20 of 50 trials
NCT04588285Phase 2Recruiting

Ambroxol in New and Early DLB, A Phase IIa Multicentre Randomized Controlled Double Blind Clinical Trial

Role: lead

NCT06774261Phase 1Completed

Phenserine on the Alzheimer's Treatment Horizon, Study 1

Role: collaborator

NCT06362707Phase 2Recruiting

Fasudil Trial for Treatment of Early Alzheimer's Disease (FEAD)

Role: collaborator

NCT06568419Not ApplicableRecruiting

eBehandling - Health and Work for Patients in Specialist Mental Health Care

Role: collaborator

NCT03540420Phase 2Active Not Recruiting

Atezolizumab After Concurrent Chemo-radiotherapy Versus Chemo-radiotherapy Alone in Limited Disease Small-cell Lung Cancer

Role: collaborator

NCT05750095Not ApplicableRecruiting

Enabling Parents of Children With Autism Spectrum Disorders - a Randomized Controlled Trial of Parenting Programs

Role: collaborator

NCT07433491Not ApplicableNot Yet Recruiting

Blue-blocking Glasses for Sleep Disorders in Child and Adolescent Psychiatry

Role: lead

NCT05223647Phase 3Terminated

Chemo-immunotherapy Plus Thoracic Radiotherapy in Extensive Stage Small-cell Lung Cancer

Role: collaborator

NCT06306586Not ApplicableRecruiting

A Digital Treatment for Adolescents With Eating Disorders

Role: collaborator

NCT03568968Phase 3Completed

A Randomized Controlled Trial of Nicotinamide Riboside Supplementation in Early Parkinson's Disease

Role: collaborator

NCT07051915Phase 3Not Yet Recruiting

The Holistic Study

Role: collaborator

NCT03271242Completed

Implementation of National Guidelines for Treatment of Psychoses

Role: collaborator

NCT06119789Phase 2Recruiting

Precision Cancer Therapy in Rare Cancers

Role: collaborator

NCT06759805Not ApplicableRecruiting

Electronic Cardiac Rehabilitation (eCardiacRehab) Feasibility Study

Role: collaborator

NCT06855121Recruiting

The Norwegian Immunotherapy in Multiple Myeloma Study

Role: collaborator

NCT06162013Phase 2Recruiting

The NADAPT Study: a Randomized Double-blind Trial of NAD Replenishment Therapy for Atypical Parkinsonism

Role: collaborator

NCT02832388Recruiting

Primary Aldosteronism in Western Norway

Role: collaborator

NCT03864094Phase 4Completed

Hemodynamics During Induction of General Anesthesia After Prophylactic Ephedrine, Phenylephrine or Norepinephrine.

Role: lead

NCT04817956Phase 2Recruiting

Improving Public Cancer Care by Implementing Precision Medicine in Norway

Role: collaborator

NCT05090527Not ApplicableCompleted

Penicillin Allergy Delabeling Project

Role: collaborator